Key Takeaways
- • CAI, a consultancy backed by JLL Partners, has signed a definitive agreement to combine with Italy's PQE Group, creating a larger global provider of quality and compliance services to life sciences companies.
- • CAI is headquartered in Florence and provides quality, compliance, validation and digital innovation services to pharmaceutical, biotech and medical device companies.
- • The deal builds on the growth capital and strategic flexibility CAI gained from its 2026 recapitalization with JLL Partners, a New York-based private equity firm.
- • The combination is intended to expand CAI's global footprint and position the company to serve clients in complex, highly regulated environments worldwide.
Summary
The agreement builds on CAI's 2026 recapitalization led by JLL Partners, a New York-based private equity firm. Publisher materials state that the recapitalization provided CAI with growth capital and strategic flexibility. Earlier company announcements noted that the recapitalization closed in July 2026, following definitive documentation, and that the investment followed CAI's recent momentum, including expanded service for global customers in Australia and new technology partnerships.
Partnership terms, valuation and deal financing were not disclosed in the available materials. The combination is expected to position the enlarged business to serve clients navigating complex, highly regulated environments around the world.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.